Skip to main content
IG

Irwin Goldstein

Biography​

Irwin Goldstein directs San Diego Sexual Medicine and sexual medicine at UC San Diego East Campus, where he is a clinical professor of urology.1 He earned his medical degree from McGill University Faculty of Medicine in 1975 and completed a urology residency at University Hospital in Boston.12 He completed a National Kidney Foundation fellowship in neurourology and erectile dysfunction at Boston University School of Medicine with Robert J. Krane.34 He is a past president of ISSWSH and the Sexual Medicine Society of North America.1

Contributions​

His cited papers cover erectile dysfunction treatments, including sildenafil, vascular stents, and penile revascularization. Other cited work addresses collagenase treatment for Peyronie's disease and the assessment and management of women's sexual dysfunction.56789

Cited on WARWIKI

18 publications with Irwin Goldstein as a listed author are cited on WARWIKI, ordered by the number of pages that cite them. Papers whose author list is shortened to "et al." before this name are not included.

  1. Dicks B, Bastuba M, Goldstein I. Penile revascularization — contemporary update. Asian J Androl. 2013;15(1):5–9. doi
    Cited on: Saphenous Vein Graft · Penile Arterial Revascularization
  2. Gelbard M, Goldstein I, Hellstrom WJ, et al. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol. 2013;190(1):199-207. doi
    Cited on: Peyronie's Disease Agents · Peyronie's Disease
  3. Sohn M, Hatzinger M, Goldstein I, Krishnamurti S. Standard operating procedures for vascular surgery in erectile dysfunction: revascularization and venous procedures. J Sex Med. 2013;10(1):172–9. doi
    Cited on: Saphenous Vein Graft · Penile Arterial Revascularization
  4. Uloko M, Goldstein I. Female Sexual Dysfunction. In: Cardozo L, Staskin D, eds. Textbook of Female Urology and Urogynecology. Vol 1: Clinical Perspectives. 5th ed. CRC Press; 2023:713-729.
    Cited on: Vestibulectomy for Localized Provoked Vestibulodynia
  5. Goldstein I, Lipshultz LI, McLane M, et al. Long-term safety and curvature deformity characterization in patients previously treated with collagenase clostridium histolyticum for Peyronie's disease. J Urol. 2020;203:1191–1197. doi
    Cited on: Peyronie's Disease Agents
  6. Goldstein I, McLane MP, Xiang Q, et al. Long-term curvature deformity characterization in men previously treated with collagenase clostridium histolyticum for Peyronie's disease, subgrouped by penile plaque calcification. Urology. 2020;146:145–151. doi
    Cited on: Peyronie's Disease Agents
  7. Aerts L, Rubin RS, Randazzo M, Goldstein SW, Goldstein I. Retrospective study of the prevalence and risk factors of clitoral adhesions: women's health providers should routinely examine the glans clitoris. Sex Med. 2018;6(2):115-122. doi
    Cited on: Clitoral Phimosis and Clitoral Adhesions
  8. Clayton AH, Goldstein I, Kim NN, et al. The International Society for the Study of Women's Sexual Health process of care for management of hypoactive sexual desire disorder in women. Mayo Clin Proc. 2018;93(4):467–487. doi
    Cited on: Female Testosterone for HSDD — Off-Label Transdermal Therapy
  9. Goldstein I, Goldstein S, Millheiser L. The impact of Fiera, a women's personal care device, on genital engorgement as measured by thermography: a proof-of-principle study. Menopause. 2017;24(11):1257-1263. doi
    Cited on: Female Sexual Dysfunction
  10. Lipshultz LI, Goldstein I, Seftel AD, et al. Clinical efficacy of collagenase clostridium histolyticum in the treatment of Peyronie's disease by subgroup. BJU Int. 2015;116:650–656. doi
    Cited on: Peyronie's Disease Agents
  11. Rogers JH, Goldstein I, Kandzari DE, et al. "Zotarolimus-Eluting Peripheral Stents for the Treatment of Erectile Dysfunction in Subjects With Suboptimal Response to Phosphodiesterase-5 Inhibitors." J Am Coll Cardiol. 2012;60(25):2618–2627. doi
    Cited on: The Penis
  12. Clayton AH, Goldfischer ER, Goldstein I, et al. Validation of the Decreased Sexual Desire Screener (DSDS): a brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD). J Sex Med. 2009;6(3):730–738. doi
    Cited on: Assessment Tools & Questionnaires

Footnotes​

  1. Meet Dr Goldstein. San Diego Sexual Medicine. Accessed October 2026. ↩ ↩2 ↩3

  2. Irwin Goldstein, MD (1950. Didusch Museum. Accessed October 2026. ↩

  3. History. Urology. Accessed October 2026. ↩

  4. URL Source: https://www.kidney.org/sites/default/files/national_kidney_foundation_the_first_40_years70_0.pdf. Accessed October 2026. ↩

  5. Gelbard M, Goldstein I, Hellstrom WJ, et al. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol. 2013;190(1):199-207. doi:10.1016/j.juro.2013.01.087 ↩

  6. Sohn M, Hatzinger M, Goldstein I, Krishnamurti S. Standard operating procedures for vascular surgery in erectile dysfunction: revascularization and venous procedures. J Sex Med. 2013;10(1):172–9. doi:10.1111/j.1743-6109.2012.02997.x ↩

  7. Dicks B, Bastuba M, Goldstein I. Penile revascularization — contemporary update. Asian J Androl. 2013;15(1):5–9. doi:10.1038/aja.2012.146 ↩

  8. Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338(20):1397–404. doi:10.1056/nejm199805143382001 ↩

  9. Rogers JH, Goldstein I, Kandzari DE, et al. "Zotarolimus-Eluting Peripheral Stents for the Treatment of Erectile Dysfunction in Subjects With Suboptimal Response to Phosphodiesterase-5 Inhibitors." J Am Coll Cardiol. 2012;60(25):2618–2627. doi:10.1016/j.jacc.2012.08.1016 ↩